Synergistic effects of proteasome inhibitor carfilzomib in combination with tyrosine kinase inhibitors in imatinib-sensitive and -resistant chronic myeloid leukemia models.

Author: Crawford LJ

Other Authors: Chan ET, Aujay M, Holyoake TL, Melo JV, Jorgensen HG, Suresh S, Walker B, Irvine AE,

Last Updated: 11/04/2019

Source: PubMed

Orignal Source: PubMed

Type: Journal Article

DOI: 10.1038/oncsis.2014.3

Journal: Oncogenesis

Volume: 3

Pages: e90

Date: March 2014

Link: Read More